Throughout my late uncle Brandon’s journey with Parkinson’s disease, my family made sure he kept up with his physical therapy. At one point, we started seeing progress. His balance seemed a little better. His confidence had improved. And he was buying into the process more than he had in…

Neuropacs’ Automated Imaging Differentiation of Parkinsonism (AIDP) software accurately detected brain changes related to Parkinson’s disease across different patient groups, including some who tested negative on standard alpha-synuclein biomarker tests, a new study has found. The software uses a specialized MRI technique called free-water imaging. These new…

When a diagnosis is made, life goes on. You walk out of your doctor’s office in a fog, wondering if this is a nightmare you’re about to wake up from. You slowly wander into the crowded elevator and can barely muster the strength to push the buttons. You somehow manage…

AC Immune has been awarded $4 million to extend the first part of an ongoing clinical trial that’s testing ACI-7104, its experimental vaccine targeting alpha-synuclein protein clumping, which is a hallmark of Parkinson’s disease. The grant, funded by the Vijay and Marie Goradia Charitable Foundation, will allow…

Parkinson’s disease takes a lot away from you. And when you are diagnosed with early-onset Parkinson’s, it can steal so much of your future. I feel lucky that nearly 13 years after my diagnosis at age 36, the majority of my symptoms are well controlled. I have…